Communication Officer - Tobacco Control
REF: 23-275_MS_EF
About the research group
Tobacco Control Research Group
The main objectives of the Tobacco Control research group (Unitat de Control del Tabac in Catalan, UCT) are to foster the current knowledge and evidence on determinants and approaches to prevent and control tobacco use, as well as tobacco smoke and e-cigarette aerosol exposure in the population. To achieve these objectives, the UCT develops interventions and epidemiological and implementation research, which includes projects such as: the impact of passive tobacco exposure in the population, the use of markers to measure tobacco smoke and electronic cigarettes aerosol in the environment or biomarkers, or the implementation of new interventions such as smoke-free homes. On the other hand, the UCT is also responsible for applied intervention projects such as the Catalan Network of Smoke-free Hospitals and health promotion services such as the smoking cessation clinic, which offers support to quit smoking to both employees and patients from ICO-IDIBELL.
The UCT currently maintains stable collaborations with national and international institutions and agencies, mainly with the Catalan Public Health Agency, and including the World Health Organization (WHO), which designated the UCT-ICO as a WHO Collaborating Centre for Tobacco Control.
The UCT’s research through the Consolidated Research Group on Epidemiology, Prevention and Tobacco Control (2021SGR00906) at the Bellvitge Biomedical Research Institute. In addition, the UCT constitutes the core of the CB19/06/00004 Group of the CIBER of Respiratory Diseases, which is funded by Instituto de Salud Carlos III.
Prof. Esteve Fernández is the leader of the Tobacco Control research group. You can read more about the research group here:
https://www.icoprevencio.cat/uct/en/
About the role
The Communication officer will develop tasks within the PIECES Project, a Horizon Europe funded project by the European Commission, coordinated by the UCT (PI: Dr. Esteve Fernández) for the period January 2024-December 2027. Specifically, the main tasks to develop will be:
• Lead the group's communication strategy for the PIECES project
• Harmonize and update the contents of the PIECES website
• Plan and create content for PIECES-related social media
• Assist in the preparation of research reports, publications, and grant proposals, ensuring they are well-structured and effectively communicate the research’s significance and impact
• Design the written communications layouts (leaflets, policy information, etc) ensuring the consistency of the UCT-ICO-IDIBELL branding
• Engage with communication agencies, government bodies, sponsors, and other stakeholders to seek opportunities to collaboration and communication of implementation strategies and research findings
• Manage external communication with media and political-administrative decision-makers
• Design and create audiovisual dissemination materials
• Plan and organize PIECES events such as seminars, workshops, conferences, and meetings
Job requirements
Professional experience
Education and training
Technical skills
Languages
We will value, but not required
- Knowledge of the European Code Against Cancer
- Knowledge of the Horizon Europe program and the Europes Cancer Beat Plan
- Ongoing studies in public health
- Team working capability, initiative and proactivity, responsibility and communication skills
What do we offer
-
-
Estimated start date: 02/01/2024
-
Contract duration: 48 months
-
Estimated annual gross salary: 26.000 €
-
You will be part of a multicultural team. We have a fun loving and friendly international work environment.
-
Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
-
Possibility to work some days in remote -Teleworking
-
26 working days of holiday per year
-
System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
-
-
Benefits of constant training are offered
-
We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Deadline: Please submit your application by 01/12/2023
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.
You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
The project leading to this labour contract has received funding from European Union under the project code 101104390.
